Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tae-Gyun Woo

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Neuro-Oncology|December 28, 2024
Therapeutic effect of novel drug candidate, PRG-N-01, on NF2 syndrome-related tumorYeon-Ho Chung, Soyoung Park, Moonyoung Lee, et al.
Molecular Cancer Research : MCR|November 3, 2021
RKIP Induction Promotes Tumor Differentiation via SOX2 Degradation in NF2-Deficient ConditionsJung-Hyun Cho, Soyoung Park, Soyeong Kim, et al.
Oncotarget|May 6, 2016
Prevention effect of rare ginsenosides against stress-hormone induced MTOC amplificationJung-Hyun Cho, Ho-Young Chun, Jung Suk Lee, et al.
Communications Biology|January 5, 2021
Progerinin, an optimized progerin-lamin A binding inhibitor, ameliorates premature senescence phenotypes of Hutchinson-Gilford progeria syndromeSo-Mi Kang, Min-Ho Yoon, Jinsook Ahn, et al.
The Journal of Clinical Investigation|September 13, 2016
Interruption of progerin-lamin A/C binding ameliorates Hutchinson-Gilford progeria syndrome phenotypeSu-Jin Lee, Youn-Sang Jung, Min-Ho Yoon, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Neuro-Oncology|December 28, 2024
Therapeutic effect of novel drug candidate, PRG-N-01, on NF2 syndrome-related tumorYeon-Ho Chung, Soyoung Park, Moonyoung Lee, et al.
Molecular Cancer Research : MCR|November 3, 2021
RKIP Induction Promotes Tumor Differentiation via SOX2 Degradation in NF2-Deficient ConditionsJung-Hyun Cho, Soyoung Park, Soyeong Kim, et al.
Oncotarget|May 6, 2016
Prevention effect of rare ginsenosides against stress-hormone induced MTOC amplificationJung-Hyun Cho, Ho-Young Chun, Jung Suk Lee, et al.
Communications Biology|January 5, 2021
Progerinin, an optimized progerin-lamin A binding inhibitor, ameliorates premature senescence phenotypes of Hutchinson-Gilford progeria syndromeSo-Mi Kang, Min-Ho Yoon, Jinsook Ahn, et al.
The Journal of Clinical Investigation|September 13, 2016
Interruption of progerin-lamin A/C binding ameliorates Hutchinson-Gilford progeria syndrome phenotypeSu-Jin Lee, Youn-Sang Jung, Min-Ho Yoon, et al.
Pageof 3